The DOI matches its Crossref record; 259 of the 261 references it cites were found in a registry or an index.
Extracellular vesicles: A bright star of nanomedicine
Open accessAbstract
Extracellular vesicles (EVs) have unique structural, compositional, and morphological characteristics as well as predominant physiochemical stability and biocompatibility properties. They play a crucial role in pathophysiological regulation, and also have broad prospects for clinical application in the diagnosis, prognosis, and therapy of disease, and tissue regeneration and repair. Herein, the biosynthesis and physiological functions and current methods for separation and identification of EVs are summarized. Specifically, engineered EVs may be used to enhance targeted therapy in cancer and repair damaged tissues, and they may be developed as an individualized imaging diagnostic reagent, among other potential applications. We will focus on reviewing recent studies on engineered EVs in which alterations enhanced their therapeutic capability or diagnostic imaging potential via physical, chemical, and biological modification approaches. This review will clarify the superior biological functions and powerful therapeutic potential of EVs, particularly with regard to new designs based on EVs and their utilization in a new generation of nanomedicine diagnosis and treatment platforms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exosomes have gained growing attention in mRNA delivery because of their good biocompatibility, low immunogenicity, small size, unique capacity to traverse physiological barriers, and cell-specific tropism.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [16]
In the citing paper
“Exosomes have gained particular interest in the field of mRNA delivery due to their unique ability to cross physiological barriers, favorable biocompatibility, low toxicity, cell-specific tropism, and ability to evade the mononuclear phagocytic system [16, 17].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [16]
Citations
Cites
1 retracted
Items 201–259 of 259
Zhu, D., Duo, Y., Suo, M., Zhao, Y., Xia, L., Zheng, Z., Yang, L., & Tang, B. Z. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003672 · Cited by 164
Exosomes: A new delivery system for tumor antigens in cancer immunotherapy
Cho, J., Yeo, D.-J., Son, H., Kim, H., Jung, D., Ko, J., Koh, J. S., Kim, Y.-N., & Kim, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20757 · Cited by 160
A Single Extracellular Vesicle (EV) Flow Cytometry Approach to Reveal EV Heterogeneity
Shen, W., Guo, K., Adkins, G. B., Jiang, Q., Liu, Y., Sedano, S., Duan, Y., Yan, W., Wang, S. E., Bergersen, K. V., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806901 · Cited by 160
Shamili, F. H., Alibolandi, M., Rafatpanah, H., Abnous, K., Mahmoudi, M., Kalantari, M. R., Taghdisi, S. M., & Ramezani, M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.032 · Cited by 157
Yang, L., Zhai, Y., Hao, Y., Zhu, Z., & Cheng, G. (2019) · Small · doi:10.1002/smll.201906273 · Cited by 157
Advancement in integrin facilitated drug delivery
Arosio, D., & Casagrande, C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.001 · Cited by 155
Lee, J., Lee, H., Goh, U., Kim, J., Jeong, M., Lee, J. Y. H., & Park, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01315 · Cited by 154
Yang, J. S., Lee, J. C., Byeon, S. K., Rha, K. H., & Moon, M. H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04634 · Cited by 152
Yang, Y., Hong, Y., Nam, G., Chung, J. H., Koh, E., & Kim, I. (2017) · Advanced Materials · doi:10.1002/adma.201605604 · Cited by 151
Wang, Q., & Lu, Q. (2017) · Nature Communications · doi:10.1038/s41467-017-00767-2 · Cited by 149
Zheng, L., Hu, X., Wu, H., Mo, L., Xie, S., Li, J., Peng, C., Xu, S., Qiu, L., & Tan, W. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11046 · Cited by 149
Zhupanyn, P., Ewe, A., Büch, T., Malek, A. V., Rademacher, P., Müller, C., Reinert, A., Jaimes, Y., & Aigner, A. M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.032 · Cited by 149
Faruqu, F. N., Wang, J. T.-W., Xu, L., McNickle, L., Chong, E. M.-Y., Walters, A. A., Gurney, M., Clayton, A., Smyth, L. A., Hider, R. C., et al. (2019) · Theranostics · doi:10.7150/thno.27891 · Cited by 146
Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping
Zheng, Z., Li, Z., Xu, C., Guo, B., & Guo, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.021 · Cited by 143
Abello, J., Nguyen, T. D. T., Marasini, R., Aryal, S., & Weiss, M. L. (2019) · Theranostics · doi:10.7150/thno.30030 · Cited by 142
Akers, J. C., Ramakrishnan, V., Nolan, J. P., Duggan, E., Fu, C.-C., Hochberg, F. H., Chen, C. C., & Carter, B. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149866 · Cited by 138
Tao, S., Rui, B., Wang, Q., Zhou, D., Zhang, Y., & Guo, S. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1425774 · Cited by 135
Wang, G., Hu, W., Chen, H., Shou, X., Ye, T., & Xu, Y. (2019) · Cancers · doi:10.3390/cancers11101560 · Cited by 129
Zhou, Y., Ma, Z., Tayebi, M., & Ai, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05749 · Cited by 127
Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy
Zhang, K., Wang, Y., Sun, J., Zhou, J. J., Xing, C., Huang, G., Li, J., & Yang, H. (2018) · Chemical Science · doi:10.1039/c8sc03224f · Cited by 126
Liu, J., Ye, Z., Xiang, M., Chang, B., Cui, J., Ji, T., Zhao, L., Li, Q., Deng, Y., Xu, L., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119475 · Cited by 121
Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy
Taghikhani, A., Farzaneh, F., Sharifzad, F., Mardpour, S., Ebrahimi, M., & Hassan, Z. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00221 · Cited by 121
Tunable Resistive Pulse Sensing for the Characterization of Extracellular Vesicles
Maas, S. L. N., Broekman, M. L. D., & de Vrij, J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6728-5_2 · Cited by 120
Phospholipase D and phosphatidic acid in the biogenesis and cargo loading of extracellular vesicles
Egea-Jiménez, A. L., & Zimmermann, P. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083964 · Cited by 120
Silva, A., Kolosnjaj‐Tabi, J., Bonneau, S., Marangon, I., Boggetto, N., Aubertin, K., Clémеnt, O., Bureau, M. F., Luciani, N., Gazeau, F., et al. (2013) · ACS Nano · doi:10.1021/nn400269x · Cited by 119
Functionalized DNA Enables Programming Exosomes/Vesicles for Tumor Imaging and Therapy
Fan, Z., Xiao, K., Lin, J., Liao, Y., & Huang, X. (2019) · Small · doi:10.1002/smll.201903761 · Cited by 115
Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers
Yerneni, S. S., Lathwal, S., Shrestha, P., Shirwan, H., Matyjaszewski, K. A., Weiss, L. E., Yolcu, E. S., Campbell, P. G., & Das, S. R. (2019) · ACS Nano · doi:10.1021/acsnano.9b04651 · Cited by 111
Dorayappan, K. D. P., Gardner, M. L., Hisey, C. L., Zingarelli, R. A., Smith, B. Q., Lightfoot, M. D. S., Gogna, R., Flannery, M. M., Hays, J. L., Hansford, D. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3538 · Cited by 109
Zhang, D., Qin, X., Wu, T., Qiao, Q., Song, Q., & Zhang, Z. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.024 · Cited by 107
Xiong, F., Ling, X., Chen, X., Chen, J., Tan, J., Cao, W., Ge, L., Ma, M., & Wu, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00824 · Cited by 103
Santana, S. M., Antonyak, M. A., Cerione, R. A., & Kirby, B. J. (2014) · Biomedical Microdevices · doi:10.1007/s10544-014-9891-z · Cited by 101
Extracellular vesicles in cancer nanomedicine
Tarasov, V. V., Svistunov, A. A., Chubarev, V. N., Dostdar, S. A., Sokolov, A. V., Brzecka, A., Sukocheva, O., Neganova, M. E., Klochkov, S. G., Somasundaram, S. G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.017 · Cited by 97
Wang, D., Yao, Y., He, J., Zhong, X., Li, B., Rao, S., Yu, H., He, S., Feng, X., Xu, T., et al. (2019) · Advanced Science · doi:10.1002/advs.201901293 · Cited by 96
Cao, H., Yue, Z. D., Gao, H., Chen, C., Cui, K., Zhang, K., Cheng, Y., Shao, G., Kong, D., Li, Z., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b09776 · Cited by 92
Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
Yang, L., Han, D., Zhan, Q., Li, X., Shan, P., Hu, Y., Ding, H., Wang, Y., Zhang, L., Zhang, Y., et al. (2019) · Theranostics · doi:10.7150/thno.37220 · Cited by 90
Nanovesicles engineered from ES cells for enhanced cell proliferation
Jeong, D., Jo, W., Yoon, J., Kim, J., Gianchandani, S., Gho, Y. S., & Park, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.047 · Cited by 89
Microfluidic on-demand engineering of exosomes towards cancer immunotherapy
Zhao, Z., McGill, J. L., Kubota, P. G., & He, M. (2019) · Lab on a Chip · doi:10.1039/c8lc01279b · Cited by 89
Lin, Q., Qu, M., Zhou, B., Patra, H. K., Sun, Z., Luo, Q., Yang, W., Wu, Y., Zhang, Y., Li, L., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.037 · Cited by 88
Youn, S., Li, Y., Kim, Y.-M., Varadarajan, S., Abdelsaid, K., Kim, H. W., Liu, Y., Fulton, D. J., Ashraf, M., Tang, Y., et al. (2019) · Antioxidants · doi:10.3390/antiox8010018 · Cited by 85
General Approach to Engineering Extracellular Vesicles for Biomedical Analysis
Di, H., Zeng, E., Zhang, P., Liu, X., Zhang, C., Yang, J. A., & Liu, D. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02268 · Cited by 82
Zhuang, M., Du, D., Pu, L., Song, H., Deng, M., Qian, L., Yin, X., Wang, Y., & Rao, L. (2019) · Small · doi:10.1002/smll.201903135 · Cited by 82
Lattanzi, L., & Federico, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.010 · Cited by 81
Generation, purification and engineering of extracellular vesicles and their biomedical applications
Gao, J., Dong, X., & Wang, Z. (2019) · Methods · doi:10.1016/j.ymeth.2019.11.012 · Cited by 77
Bonito, P. D., Chiozzini, C., Arenaccio, C., Anticoli, S., Manfredi, F., Olivetta, E., Ferrantelli, F., Falcone, E., Ruggieri, A., & Federico, M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131309 · Cited by 71
Palma, M., Hansson, L., Choudhury, A., Näsman‐Glaser, B., Eriksson, I., Adamson, L., Rossmann, E. D., Widén, K., Horváth, R., Kokhaei, P., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1149-5 · Cited by 68
Rapid Detection of Exosomal MicroRNAs Using Virus‐Mimicking Fusogenic Vesicles
Gao, X., Li, S., Ding, F., Fan, H.-J., Shi, L., Zhu, L., Li, J., Feng, J. C., Zhu, X., & Zhang, C. (2019) · Angewandte Chemie · doi:10.1002/ange.201901997 · Cited by 65
Folate-Engineered Microvesicles for Enhanced Target and Synergistic Therapy toward Breast Cancer
Zhu, L. Q., Dong, D., Yu, Z., Zhao, Y., Pang, D., & Zhang, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14633 · Cited by 64
Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9
Gulei, D., & Berindan‐Neagoe, I. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.032 · Cited by 51
Shen, L., Quan, L., & Liu, J. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b00601 · Cited by 49
Ferrantelli, F., Manfredi, F., Chiozzini, C., Anticoli, S., Olivetta, E., Arenaccio, C., & Federico, M. (2018) · Molecular Biotechnology · doi:10.1007/s12033-018-0114-3 · Cited by 43
Enrichment of extracellular vesicles with lipid nanoprobe functionalized nanostructured silica
Wan, Y., Maurer, M., He, H.-Z., Xia, Y.-Q., Hao, S.-J., Zhang, W.-L., Yee, N. S., & Zheng, S. (2019) · Lab on a Chip · doi:10.1039/c8lc01359d · Cited by 38
Matsumoto, A., Takahashi, Y., Ariizumi, R., Nishikawa, M., & Takakura, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119518 · Cited by 35
Zhu, D., Duo, Y., Suo, M., Zhao, Y., Xia, L., Zheng, Z., Yang, L., & Tang, B. Z. (2020) · Angewandte Chemie · doi:10.1002/ange.202003672 · Cited by 35
Anticoli, S., Aricò, E., Arenaccio, C., Manfredi, F., Chiozzini, C., Olivetta, E., Ferrantelli, F., Lattanzi, L., D’Urso, M. T., Proietti, E., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1617-2 · Cited by 34
Modified Exosomes Reduce Apoptosis and Ameliorate Neural Deficits Induced by Traumatic Brain Injury
Wang, B., & Han, S. (2018) · ASAIO Journal · doi:10.1097/mat.0000000000000810 · Cited by 31
Chen, W., Yang, M., Bai, J., Li, X., Kong, X., Gao, Y., Bi, L., Li, X., & Shi, B. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700242 · Cited by 28
Glumm, J., & Neubert, J. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.175043 · Cited by 20
Nishio, M., Teranishi, Y., Morioka, K., Yanagida, A., & Shoji, A. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111918 · Cited by 16
Introduction to the Thematic Review Series on Extracellular Vesicles: a focus on the role of lipids
Record, M. (2018) · Journal of Lipid Research · doi:10.1194/jlr.e086132 · Cited by 10
Flagged first, then by citations
2 of the 261 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Skotland, 1990, 70, 122
- Li, 2020, Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer, Nanoscale, 12, 10854, 10.1039/D0NR00523A · DOI
Cited by
Sorted by citations
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 591
Bella, M. A. D. (2022) · Biology · doi:10.3390/biology11060804 · Cited by 322
Cancer nanomedicine: a review of nano-therapeutics and challenges ahead
Nirmala, M. J., Kizhuveetil, U., Johnson, A., Govindaswamy, B., Nagarajan, R., & Muthuvijayan, V. (2023) · RSC Advances · doi:10.1039/d2ra07863e · Cited by 222
Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells
D’souza, A. A., Burch, A. M., Dave, K. M., Sreeram, A., Reynolds, M. J., Dobbins, D. X., Kamte, Y. S., Zhao, W., Sabatelle, C., Joy, G. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.038 · Cited by 194
Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
Mosquera-Heredia, M. I., Morales, L. C., Vidal, O. M., Barceló, E., Silvera-Redondo, C. A., Velez, J. I., & Garavito, P. (2021) · Biomedicines · doi:10.3390/biomedicines9081061 · Cited by 173
Metadata
- Authors
- Wu, P., Zhang, B., Ocansey, D. K. W., Xu, W., & Qian, H.
- Affiliations
- Jiangsu University (CN)
- Affiliated Hospital of Jining Medical University (CN)
- Corresponding author
- Xu, Wenrong
- Qian, Hui
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 269
- Pages
- 120467
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W3096805091
- Cited by
- 368
- References
- 261
- Citations by year
- 2026: 38 · 2025: 51 · 2024: 72 · 2023: 87 · 2022: 74 · 2021: 44
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biomaterials (acceptedVersion)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- Jiangsu Provincial Key Research and Development Program
- National Natural Science Foundation of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- extracellular vesicles, engineered extracellular vesicles, nanomedicine, targeted cancer therapy, tissue regeneration, diagnostic imaging, disease diagnosis and prognosis
- MeSH terms
- Extracellular Vesicles, Humans, Neoplasms, Nanomedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
